Good morning, everyone, and how are you today? A spot of rain is falling on the Pharmalot corporate campus, but our spirits remain sunny. After all, as the Morning Mayor used to say: 'Every brand new day should be unwrapped like a precious gift.' So go ahead and tug on the ribbon. Who knows what tomorrow brings? While you contemplate, please join us for a delicious cup of stimulation. And of course, here are some tidbits to help you get moving, too. Have a great day and stay in touch...
Sanofi Recalls Nine Lots Of Kidney Transplant Rejection Drug (Reuters)
FDA Approves Gilead Quad Pill For HIV (Pharma Times)
Novartis Gets EU Approval For Blood Cancer Drug (Reuters)
Forest Adopts Poison Pill After Icahn Stake (Dow Jones)
Cipla To Shift Headquarters (Economic Times)
Agennix Slashes Job After Lung Cancer Drug Failure (Pharma Times)
FDA Halts Testing Of Another Idenix Drug (Associated Press)
Caraco Receives FDA OK To Resume US Operations (Dow Jones)
EDITOR'S NOTE: Please check this post for updates during the day